RENAL CARCINOMA
Clinical trials for RENAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL CARCINOMA trials appear
Sign up with your email to follow new studies for RENAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests whether a new immune cell therapy called CIML NK cells, combined with a low dose of IL-2, is safe and feasible for people with advanced kidney or bladder cancers. The therapy uses a patient's own immune cells that are trained in a lab to better recogn…
Matched conditions: RENAL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
Blood test breakthrough could spot kidney cancer sooner
Diagnosis OngoingThis study looks at whether specific antibodies in the blood can help detect kidney cancer earlier and predict how the disease will progress. Researchers will analyze data from 400 patients to build a model that guides personalized treatment and avoids unnecessary risks. The goal…
Matched conditions: RENAL CARCINOMA
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated May 17, 2026 02:06 UTC